Tiemann Investment Advisors’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $268K | Sell |
2,122
-75
| -3% | -$9.88K | 0.1% | 155 |
|
|
2026
Q1 | $306K | Sell |
2,197
-100
| -4% | -$14K | 0.12% | 139 |
|
|
2025
Q4 | $282K | Hold |
2,297
| – | – | 0.11% | 142 |
|
|
2025
Q3 | $255K | Hold |
2,297
| – | – | 0.1% | 166 |
|
|
2025
Q2 | $255K | Sell |
2,297
-105
| -4% | -$11.2K | 0.1% | 155 |
|
|
2025
Q1 | $269K | Buy |
+2,402
| New | +$248K | 0.12% | 146 |
|
|
2024
Q1 | – | Sell |
-2,477
| Closed | -$201K | – | 199 |
|
|
2023
Q4 | $201K | Buy |
+2,477
| New | +$193K | 0.1% | 184 |
|
|
2023
Q3 | – | Sell |
-2,412
| Closed | -$186K | – | 189 |
|
|
2023
Q2 | $186K | Buy |
2,412
+30
| +1% | +$2.39K | 0.09% | 192 |
|
|
2023
Q1 | $198K | Buy |
2,382
+55
| +2% | +$4.55K | 0.11% | 188 |
|
|
2022
Q4 | $200K | Buy |
+2,327
| New | +$184K | 0.12% | 185 |
|
|
2022
Q1 | – | Sell |
-3,277
| Closed | -$238K | – | 218 |
|
|
2021
Q4 | $238K | Buy |
+3,277
| New | +$226K | 0.1% | 194 |
|
|
2021
Q2 | – | Sell |
-3,242
| Closed | -$210K | – | 213 |
|
|
2021
Q1 | $210K | Buy |
3,242
+32
| +1% | +$2.06K | 0.1% | 198 |
|
|
2020
Q4 | $187K | Sell |
3,210
-80
| -2% | -$4.83K | 0.1% | 201 |
|
|
2020
Q3 | $208K | Sell |
3,290
-525
| -14% | -$36.4K | 0.13% | 172 |
|
|
2020
Q2 | $294K | Buy |
3,815
+530
| +16% | +$40.6K | 0.2% | 128 |
|
|
2020
Q1 | $246K | Buy |
+3,285
| New | +$227K | 0.21% | 123 |
|
|
2018
Q4 | – | Sell |
-3,171
| Closed | -$245K | – | 164 |
|
|
2018
Q3 | $245K | Buy |
+3,171
| New | +$239K | 0.19% | 150 |
|
|
2018
Q2 | – | Sell |
-2,965
| Closed | -$224K | – | 175 |
|
|
2018
Q1 | $224K | Hold |
2,965
| – | – | 0.18% | 155 |
|
|
2017
Q4 | $212K | Hold |
2,965
| – | – | 0.17% | 163 |
|
|
2017
Q3 | $240K | Buy |
2,965
+100
| +3% | +$7.65K | 0.2% | 145 |
|
|
2017
Q2 | $203K | Sell |
2,865
-325
| -10% | -$21.6K | 0.18% | 157 |
|
|
2017
Q1 | $217K | Buy |
3,190
+150
| +5% | +$10.5K | 0.2% | 153 |
|
|
2016
Q4 | $218K | Buy |
3,040
+115
| +4% | +$8.55K | 0.21% | 137 |
|
|
2016
Q3 | $231K | Sell |
2,925
-1,075
| -27% | -$87.3K | 0.21% | 145 |
|
|
2016
Q2 | $334K | Sell |
4,000
-450
| -10% | -$39.9K | 0.31% | 102 |
|
|
2016
Q1 | $409K | Buy |
4,450
+550
| +14% | +$49.6K | 0.4% | 75 |
|
|
2015
Q4 | $395K | Buy |
3,900
+10
| +0.3% | +$1.04K | 0.4% | 73 |
|
|
2015
Q3 | $382K | Buy |
3,890
+100
| +3% | +$11.1K | 0.42% | 74 |
|
|
2015
Q2 | $444K | Buy |
3,790
+100
| +3% | +$10.9K | 0.46% | 69 |
|
|
2015
Q1 | $362K | Buy |
3,690
+970
| +36% | +$98.5K | 0.38% | 86 |
|
|
2014
Q4 | $256K | Sell |
2,720
-485
| -15% | -$50.2K | 0.28% | 117 |
|
|
2014
Q3 | $341K | Buy |
3,205
+140
| +5% | +$13.7K | 0.38% | 92 |
|
|
2014
Q2 | $254K | Hold |
3,065
| – | – | 0.28% | 118 |
|
|
2014
Q1 | $217K | Sell |
3,065
-80
| -3% | -$6.27K | 0.24% | 134 |
|
|
2013
Q4 | $236K | Buy |
+3,145
| New | +$219K | 0.28% | 120 |
|
Other funds holding GILD
Tiemann Investment Advisors's GILD Position: Q2 2026 in Review
Tiemann Investment Advisors reduced its Gilead Sciences (GILD) stake by 3.4% in Q2 2026, selling an estimated $9.88K and leaving 2,122 shares worth $268K. The position accounts for 0.1% of the portfolio, ranked #155.
Tiemann Investment Advisors first reported a position in GILD in Q4 2013 and has held it in 35 quarters since. The position peaked at $444K in Q2 2015. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Tiemann Investment Advisors held 2,122 shares of Gilead Sciences worth $268K as of Q2 2026.
- Tiemann Investment Advisors sold 75 Gilead Sciences shares in Q2 2026, an estimated $9.88K.
- Gilead Sciences made up 0.1% of Tiemann Investment Advisors's portfolio in Q2 2026, its #155 holding.
- Tiemann Investment Advisors first reported a position in Gilead Sciences in Q4 2013 and has held it in 35 quarters since.
- Tiemann Investment Advisors's Gilead Sciences position peaked at $444K in Q2 2015.
- 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Tiemann Investment Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.